Ultrasound

ContextVision reaches milestoneFDA clears Barco cardiac analysisDynamic Imaging taps new executiveMedrad plans to expand production of sterile disposables

GE equipment performs CT helical shuttle, dual-energy scansUltrasound for iPodsEclipsys to acquire lab software companyGE releases CardIQ Fusion

GE Healthcare upgrades echo systemKonica extends mobile stitchingFDA clears Medrad pumpSiemens introduces syngo ultrasoundTim reaches 1000th customer

Future cancer management may rely on identifying healthy individuals at risk before they develop symptoms of disease, according to National Cancer Institute researchers.

Enthusiasm about ultrasound as a complementary screening tool for women with dense breasts may be unfounded, according to an Italian radiologist who presented study findings at the European Congress of Radiology in Vienna. But a U.S. luminary has a different opinion.

Born in the U.S. and incubated in research facilities for more than 15 years, ultrasound elastography emerged with a splash across the Atlantic at the 2006 European Congress of Radiology. Researchers at the March meeting hailed the technique's potential to dramatically reduce benign breast biopsy rates.

Cedara teams with German RIS firmVarian Medical expands in China FTC delays Suros acquisition, R2 deal on trackSuros, SenoRx bury hatchetLegacy support arrives for CV PACS

GE debuts ER ultrasound scannersFDA expands use of Varian platformCanadians tap Agfa for PACSToshiba reaches MR milestoneHansen highlights robotic catheter system

FDA clearances dipped in April compared with their spike in March, but the latest month put the industry back on track with previous years’ performance, outshining five of the past six Aprils with 28. That brings the total to 80 clearances this year -- in the ballpark with, though still lagging behind, industry performance since 2000.

Philips tops U.S. ultrasound marketStereotaxis, Siemens extend allianceMerge changes senior management teamViatronix appoints business development director

A study by Mayo Clinic researchers suggests MR elastography could provide noninvasive diagnosis of hepatic fibrosis, potentially reducing the need for biopsy.

3D cardiac software debutsRIS/PACS sales boost Agfa performanceGE collaborates with St. Jude Medical

GE launches new laptop ultrasound unitsGamma Medica-Ideas selects Asian distributorsDamadian buys Fonar shares on open marketDMS Health Group taps new CFO

An unusual eulogy delivered at ECR came from a urologist during a prostate cancer imaging session. The topic focused on a physical test that men have come to know, if not exactly love.

Enthusiasm about ultrasound as a complementary tool for screening women with dense breasts may be exaggerated or even unfounded, according to an Italian radiologist speaking at the European Congress of Radiology.

Fonar stumbles, blames competitorsSonoSite revenues edge upwardAurora closes $10 million investment Demand for radiosurgery system grows

Blade, MR prototype on cutting edge at ISMRMPhilips upgrades ultrasound at ACOG meetingGE launches densitometer at ACOG meetingSiemens installs first Symbia S

Image-guided percutaneous biopsy is safe and accurate, and it holds potential for eliminating needless nephrectomies, according to two studies presented at the American Roentgen Ray Society meeting in Vancouver.

Emory operates 64-slice PET/CTIMV study shows ultrasound expanding

GE Healthcare introduced today a miniaturized version of its 4D ultrasound system for women’s health and prenatal applications. The Voluson i is about the size of a laptop yet produces real-time volumetric images and displays them on a screen as big as the company’s cart-based 4D Voluson 730.

A California lawmaker has announced a bill that would restrict sales of ultrasound machines to medical professionals. The move follows public safety concerns raised by actor Tom Cruise’s November 2005 purchase of sophisticated equipment to perform ultrasound exams on his pregnant fiancée.

Portable ultrasound meets laptopR2 allies with GECedara and Swissray team upEclipsys revenues rise 19%U.S. Electronics unveils 5-MP display at SIIMNeurostar boosts network capabilitiesBrit Systems enhances image management

Percutaneous cryoablation of renal tumors is 100% effective, according to a report presented Monday at the American Roentgen Ray Society meeting.

For years, interventional radiologists have seen vascular disease management slip through their fingers and into the hands of cardiologists and surgeons. A new ultrasound-based technique, however, may help them reclaim lost turf.

SonoSite allies with Siemens in GermanyFDA approves optimized digital mammography unitCommissure launches RadCube suite

Schering boards recommend Bayer bidKodak plans product unveilings at SCAR meetingTomTec unveils 4D cardiac packageiCAD, R2 split decision in patent arbitrationCerner snags Australian contract

The industry rebounded in March from a sluggish start to the year as the FDA cleared 34 devices under 510(k) review, nearly matching the number cleared in the previous two months together. March brought the total to 72 radiological devices cleared so far in 2006, making up for the slow start and putting vendors on track with previous years.

Researchers from Seoul National University Medical Center have found that breast cancers detected by ultrasound only are not very sensitive to computer-aided detection.

Renal cell cancer is the most frequently encountered malignant tumor in the kidney. Over 30,000 new cases are diagnosed annually in the U.S. Many cases are now detected incidentally, as a result of the widespread use of multislice CT. MSCT usage is also redefining diagnostic workup of renal lesions and facilitating renal cell cancer staging.

Ultrasound provides a safe and accurate method of detecting breast cancer and assessing response to chemotherapy in pregnant women, according to a study in the April issue of Radiology.